Radiological tumor classification across imaging modality and histology.


Journal

Nature machine intelligence
ISSN: 2522-5839
Titre abrégé: Nat Mach Intell
Pays: England
ID NLM: 101740243

Informations de publication

Date de publication:
Sep 2021
Historique:
entrez: 29 11 2021
pubmed: 30 11 2021
medline: 30 11 2021
Statut: ppublish

Résumé

Radiomics refers to the high-throughput extraction of quantitative features from radiological scans and is widely used to search for imaging biomarkers for prediction of clinical outcomes. Current radiomic signatures suffer from limited reproducibility and generalizability, because most features are dependent on imaging modality and tumor histology, making them sensitive to variations in scan protocol. Here, we propose novel radiological features that are specially designed to ensure compatibility across diverse tissues and imaging contrast. These features provide systematic characterization of tumor morphology and spatial heterogeneity. In an international multi-institution study of 1,682 patients, we discover and validate four unifying imaging subtypes across three malignancies and two major imaging modalities. These tumor subtypes demonstrate distinct molecular characteristics and prognoses after conventional therapies. In advanced lung cancer treated with immunotherapy, one subtype is associated with improved survival and increased tumor-infiltrating lymphocytes compared with the others. Deep learning enables automatic tumor segmentation and reproducible subtype identification, which can facilitate practical implementation. The unifying radiological tumor classification may inform prognosis and treatment response for precision medicine.

Identifiants

pubmed: 34841195
doi: 10.1038/s42256-021-00377-0
pmc: PMC8612063
mid: NIHMS1718815
doi:

Types de publication

Journal Article

Langues

eng

Pagination

787-798

Subventions

Organisme : NCI NIH HHS
ID : R01 CA222512
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA233578
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA218667
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA193730
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA218667
Pays : United States

Déclaration de conflit d'intérêts

Competing interests The authors declare no potential conflicts of interest.

Références

Radiology. 2018 Aug;288(2):407-415
pubmed: 29688159
Nat Rev Clin Oncol. 2020 Sep;17(9):555-568
pubmed: 32528101
Biostatistics. 2007 Jan;8(1):9-31
pubmed: 16613834
Sci Rep. 2021 May 28;11(1):11280
pubmed: 34050208
Ann Oncol. 2020 Jun;31(6):760-768
pubmed: 32240794
Sci Transl Med. 2015 Sep 2;7(303):303ra138
pubmed: 26333934
Lancet Oncol. 2018 Sep;19(9):1180-1191
pubmed: 30120041
Neuro Oncol. 2012 Jul;14(7):942-54
pubmed: 22711606
Nat Cell Biol. 2018 Dec;20(12):1349-1360
pubmed: 30482943
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Ann Oncol. 2017 Jun 1;28(6):1191-1206
pubmed: 28168275
Sci Rep. 2020 Mar 3;10(1):3894
pubmed: 32127569
J Magn Reson Imaging. 2019 Jun;49(7):e101-e121
pubmed: 30451345
Nat Med. 2018 Oct;24(10):1559-1567
pubmed: 30224757
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
J Nucl Med. 2020 Mar;61(3):327-336
pubmed: 31420498
PLoS One. 2015 May 04;10(5):e0124165
pubmed: 25938522
Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1504-1512
pubmed: 27212196
Nat Rev Clin Oncol. 2017 Mar;14(3):169-186
pubmed: 27725679
Cancers (Basel). 2020 Jun 24;12(6):
pubmed: 32599906
Breast Cancer Res. 2017 May 18;19(1):57
pubmed: 28521821
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Science. 2018 Oct 12;362(6411):
pubmed: 30309915
Immunity. 2018 Apr 17;48(4):812-830.e14
pubmed: 29628290
Nature. 2009 Nov 5;462(7269):108-12
pubmed: 19847166
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1143-1158
pubmed: 30170872
Nat Commun. 2020 Sep 25;11(1):4861
pubmed: 32978398
Radiother Oncol. 2019 Jan;130:2-9
pubmed: 30416044
Radiology. 2018 Jul;288(1):26-35
pubmed: 29714680
Lancet Digit Health. 2019 Jul;1(3):e136-e147
pubmed: 31448366
Invest Radiol. 2015 Nov;50(11):757-65
pubmed: 26115366
Lancet Digit Health. 2021 Jun;3(6):e371-e382
pubmed: 34045003
Breast Cancer Res. 2018 Sep 3;20(1):101
pubmed: 30176944
Lancet Digit Health. 2020 Mar;2(3):e116-e128
pubmed: 32123864
Sci Transl Med. 2013 May 29;5(187):187ps9
pubmed: 23720579
Lancet Oncol. 2019 May;20(5):728-740
pubmed: 30952559
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929

Auteurs

Jia Wu (J)

Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.
Department of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA.
Department of Thoracic and Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

Chao Li (C)

The Centre for Mathematical Imaging in Healthcare, Department of Pure Mathematics and Mathematical Statistics, University of Cambridge, UK.
Cambridge Brain Tumor Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Michael Gensheimer (M)

Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.

Sukhmani Padda (S)

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

Fumi Kato (F)

Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.

Hiroki Shirato (H)

Global Center for Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.

Yiran Wei (Y)

Cambridge Brain Tumor Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Carola-Bibiane Schönlieb (CB)

Department of Applied Mathematics and Theoretical Physics, University of Cambridge, UK.

Stephen John Price (SJ)

Cambridge Brain Tumor Imaging Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

David Jaffray (D)

Department of Imaging Physics, MD Anderson Cancer Center, Houston, TX, USA.
Office of the Chief Technology and Digital Officer, MD Anderson Cancer Center, Houston, TX, USA.

John Heymach (J)

Department of Thoracic and Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.

Joel W Neal (JW)

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

Billy W Loo (BW)

Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.

Heather Wakelee (H)

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA.

Maximilian Diehn (M)

Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.

Ruijiang Li (R)

Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.

Classifications MeSH